glp 1 foot pain GLP-1 medications like Ozempic®, Wegovy®, and Mounjaro® are transforming weight loss — but many patients don't realize rapid weight loss can also affect the feet. As body mass changes, patients may experience: • Ozempic feet': Side effect causes

learn more.

Novo Nordisk is evaluating a long-acting semaglutide implant designed to keep GLP-1 patients on treatment for months at a time and food and drink manufacturers should be watching closely.

Starts at $149/mo on the 6-month plan all-inclusive, covering async provider consultation, prescription, compounded Semaglutide medication, and shipping

Two new oral medications for weight management are coming to the UK

Never compromise on potency during travel

Beyond these frontrunners, the pipeline is expanding: Novo Nordisk filed for FDA approval of CagriSema in 2025, the first once-weekly combination of GLP1 and amylin analogue